Janssen (Johnson & Johnson) Turkey

Best known as the company that launched the world’s first “antibody biosimilar,” Celltrion is looking to…

Evren Özlü, General Manager of Turkey and Sub-Saharan Africa at Boehringer Ingelheim, discusses the company’s…

Polifarma is a Turkish pharma company dedicated to the hospital sector and biosimilars. Its chairman, Ufuk Kumrulu,…

Drawing on over a dozen interviews with C-level pharmaceutical industry executives in Turkey, PharmaBoardroom has…

The president of the Investment Office of the Presidency of the Republic of Turkey, Burak Dağlıoğlu, outlines…

Muzaffer Bal, CEO of Ali Raif, a Turkish generics firm, highlights the company’s new investment in a…

Süha Taşpolatoğlu, CEO of Abdi Ibrahim, Turkish pharma’s “national champion”, discusses the company’s…

Ilko Pharmaceuticals is a family-owned Turkish generics and biosimilars company. General Manager Hatice Öncel…

Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and…

Ismail Yormaz, Recordati’s VP and regional director for south-east, highlights how the Milan-based company has…

Almost two decades after initiating large-scale health system reforms, Turkey has consolidated the provision of…

Takeda’s general manager for Turkey, Şeyda Atadan Memiş, reflects on the Japanese giant’s ambitions in Turkey…

Company description